You are here

University of California San Francisco

745 Parnassus Ave
San Francisco, CA 94143
United States

Mentor Name: William Weiss

Mentor Name: Zulekha Qadeer

Mentor Name: Amit Sabnis

Osteosarcoma is a bone tumor occurring most often in children and young adults. These patients have a 5-year survival rate of less than 20% if the cancer has spread to distant sites at the time of diagnosis.

While immunotherapy has been highly successful in pediatric leukemia, results with solid tumors have been disappointing. As an example, high-risk neuroblastoma (NB) is adept at evading the immune system. and frequently presents with extensive incurable wide spread disease. Clinical observations indicated the potential for strong interactions between NB tumor cells and host immune cells and sparked early enthusiasm for immunotherapy.

Mentor: Kevin Shannon

Mentor: Dr. Elliot Stieglitz

Mentor: Dr. William Weiss

Fusion-negative sarcomas are a diverse and understudied subset of pediatric cancers. The most prevalent are embryonal rhabdomyosarcoma (ERMS) and osteosarcoma (OS). Osteosarcoma is characterized by an abnormal genome with many alterations, most of which are called “copy number gains” or “copy number losses.” In a normal genome, there are only two copies of every gene. However, in OS many genes have more than 4 copies, sometimes even 10 or more copies.

Pages